Cancer Chemotherapy and Pharmacology, 90(1), 97-104. Springer Verlag Cancer Chemotherapy and Pharmacology, 90(1), 97-104. SPRINGER van Berge Henegouwen, J M, van der Wijngaart, H, Zeverijn, L J, Hoes, L R, Meertens, M, Huitema, A D R, Devriese, L A, Labots, M, Verheul, H M W, Voest, E E & Gelderblom, H 2022, ' Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer : a case series and review of literature ', Cancer Chemotherapy and Pharmacology, vol. 90, no. 1, pp. 97-104 . https://doi.org/10.1007/s00280-022-04437-z
European Journal of Cancer, 171, 114-123. ELSEVIER SCI LTD van Berge Henegouwen, J M, Jebbink, M, Hoes, L R, van der Wijngaart, H, Zeverijn, L J, van der Velden, D L, Roepman, P, de Leng, W W J, Jansen, A M L, van Werkhoven, E, van der Noort, V, van der Wekken, A J, de Langen, A J, Voest, E E, Verheul, H M W, Smit, E F & Gelderblom, H 2022, ' Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer ', European Journal of Cancer, vol. 171, pp. 114-123 . https://doi.org/10.1016/j.ejca.2022.05.009 European Journal of Cancer, 171, 114-123. Pergamon European Journal of Cancer, 171, 114-123. Elsevier Limited European Journal of Cancer, 171, pp. 114-123 European Journal of Cancer, 171, 114-123